Anmol Ahuja1, Om Tantia2, Tamonas Chaudhuri1, Shashi Khanna1, Shivakumar Seetharamaiah1, Kajari Majumdar1, Ghanshyam Goyal1. 1. Department of Minimal Access & Bariatric Surgery, ILS Hospitals, DD-6, Sector 1, Salt Lake City, Kolkata, West Bengal, 700064, India. 2. Department of Minimal Access & Bariatric Surgery, ILS Hospitals, DD-6, Sector 1, Salt Lake City, Kolkata, West Bengal, 700064, India. omtantia@gmail.com.
Abstract
BACKGROUND: Obesity is one of the major causes for development of T2DM. Metabolic surgery has been proved to be a successful and cost-effective treatment modality for managing the patients with obesity and T2DM. Many scoring systems and models have been described in literature to predict the outcome of T2DM after metabolic surgery. The aim of this study is to compare the efficacy of Diarem, DRS, and ABCD score in predicting the T2DM remission. METHODS: A total number of 102 diabetic patients, who underwent LMGB/LOAGB, were selected for this study. A retrospective analysis of the three scoring systems when applied to these patients and their predictive abilities were analyzed. RESULTS: At 1 year after surgery, 72 (70.59%) patients achieved remission of T2DM. Though the pairwise comparisons between AUC on ROC analysis of ABCD, Diarem, and DRS scores does not show statistically significant difference between them, Diarem score has the maximum relative area under ROC curves. By multivariate analysis, it was found that factors significantly associated with T2DM remission were duration of T2DM, C-peptide, and Pre-Op HbA1c. CONCLUSIONS: Among the three scoring systems, though DiaRem score has the best sensitivity and specificity and maximum AUC, no statistically significant difference was found in their diabetes remission predicting abilities. A shorter duration of T2DM, a lower HbA1C, and higher levels of C-peptide were significantly associated with a higher chance of T2DM remission.
BACKGROUND:Obesity is one of the major causes for development of T2DM. Metabolic surgery has been proved to be a successful and cost-effective treatment modality for managing the patients with obesity and T2DM. Many scoring systems and models have been described in literature to predict the outcome of T2DM after metabolic surgery. The aim of this study is to compare the efficacy of Diarem, DRS, and ABCD score in predicting the T2DM remission. METHODS: A total number of 102 diabeticpatients, who underwent LMGB/LOAGB, were selected for this study. A retrospective analysis of the three scoring systems when applied to these patients and their predictive abilities were analyzed. RESULTS: At 1 year after surgery, 72 (70.59%) patients achieved remission of T2DM. Though the pairwise comparisons between AUC on ROC analysis of ABCD, Diarem, and DRS scores does not show statistically significant difference between them, Diarem score has the maximum relative area under ROC curves. By multivariate analysis, it was found that factors significantly associated with T2DM remission were duration of T2DM, C-peptide, and Pre-Op HbA1c. CONCLUSIONS: Among the three scoring systems, though DiaRem score has the best sensitivity and specificity and maximum AUC, no statistically significant difference was found in their diabetes remission predicting abilities. A shorter duration of T2DM, a lower HbA1C, and higher levels of C-peptide were significantly associated with a higher chance of T2DM remission.
Entities:
Keywords:
AUC (area under curve); LMGB (laparoscopic mini gastric bypass); LOAGB (laparoscopic one anastamosis gastric bypass); ROC (receiver operating curve); T2DM (type 2 diabetes mellitus)
Authors: Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel Journal: N Engl J Med Date: 2004-12-23 Impact factor: 91.245
Authors: Maurizio De Luca; Luigi Angrisani; Jacques Himpens; Luca Busetto; Nicola Scopinaro; Rudolf Weiner; Alberto Sartori; Christine Stier; Muffazal Lakdawala; Aparna G Bhasker; Henry Buchwald; John Dixon; Sonja Chiappetta; Hans-Christian Kolberg; Gema Frühbeck; David B Sarwer; Michel Suter; Emanuele Soricelli; Mattias Blüher; Ramon Vilallonga; Arya Sharma; Scott Shikora Journal: Obes Surg Date: 2016-08 Impact factor: 4.129
Authors: John B Buse; Sonia Caprio; William T Cefalu; Antonio Ceriello; Stefano Del Prato; Silvio E Inzucchi; Sue McLaughlin; Gordon L Phillips; R Paul Robertson; Francesco Rubino; Richard Kahn; M Sue Kirkman Journal: Diabetes Care Date: 2009-11 Impact factor: 19.112
Authors: George Tharakan; Rebecca Scott; Olivia Szepietowski; Alexander D Miras; Alexandra I Blakemore; Sanjay Purkayastha; Ahmed Ahmed; Harvinder Chahal; Tricia Tan Journal: Obes Surg Date: 2017-03 Impact factor: 4.129
Authors: Maurizio De Luca; Giacomo Piatto; Giovanni Merola; Jacques Himpens; Jean-Marc Chevallier; Miguel-A Carbajo; Kamal Mahawar; Alberto Sartori; Nicola Clemente; Miguel Herrera; Kelvin Higa; Wendy A Brown; Scott Shikora Journal: Obes Surg Date: 2021-05-03 Impact factor: 4.129
Authors: Kajsa Sjöholm; Lena M S Carlsson; Magdalena Taube; Carel W le Roux; Per-Arne Svensson; Markku Peltonen Journal: Diabetes Care Date: 2020-09-01 Impact factor: 19.112
Authors: Kristina H Lewis; David E Arterburn; Fang Zhang; Katherine Callaway; Jamie Wallace; Adolfo Fernandez; Dennis Ross-Degnan; James F Wharam Journal: Ann Surg Date: 2021-05-01 Impact factor: 13.787
Authors: Ana de Hollanda; Albert Lecube; Miguel Angel Rubio; Enric Sánchez; Núria Vilarrasa; José Gregorio Oliva; María Luisa Fernández-Soto; Jordi Salas-Salvadó; María D Ballesteros-Pomar; Andreea Ciudin; Ferran Torres; Concepción Vidal; María José Morales; Sergio Valdés; Silvia Pellitero; Inka Miñambres; Lluís Masmiquel; Albert Goday; Lorena Suarez; Liliam Flores; Marta Bueno; Assumpta Caixàs; Irene Bretón; Rosa Cámara; Romina Olbeyra; Rona Penso; María José de la Cruz; Andreu Simó-Servat; Francisca María Pereyra-García; Elena Teresa López-Mezquita; Anna Gils; Enzamaria Fidilio; Orosia Bandrés; Ángel Martínez; Jose Abuín; Montserrat Marques-Pamies; Laura Tuneu; Magdalena Arteaga; Olga Castañer; Fernando Goñi; Cristina Arrizabalaga; Manuel Antonio Botana; Alfonso Calañas; Ángel Rebollo Journal: J Clin Med Date: 2020-04-09 Impact factor: 4.241